Walgreens to start offering ‘smart’ medicines for people with heart problems
The world’s largest pharmacy chain is to start rolling out a new version of its “smart” medicine for heart failure.
The Food and Drug Administration said it is looking to roll out a “smart drug” to treat patients with heart failure, chronic obstructive pulmonary disease and congestive heart failure who require medication that can be prescribed through an app, a company spokesman said on Monday.
“This is a step in the right direction to bring us closer to delivering the right medicine at the right time,” David Smith, vice president of health services for Walgreen, said in a statement.
The company, which was founded in 1905, started offering its “Heart & Pain” drug in the US in 2017 and is also developing a new drug, according to the FDA.
It is currently available only in Europe.
“The new drug will provide patients with a safer, more effective alternative to the current medications that currently exist,” FDA Commissioner Scott Gottlieb said in the statement.
The FDA is still evaluating how many people will be able to take the drug, which costs about $2,500 a year.
It has not yet announced a timetable for when it will roll out the new product.
In the meantime, the new drug is expected to be available in a limited number of locations, including Walgreeks pharmacy and the Walgreek Pharmacy in Manhattan.
The Drug Enforcement Administration also has opened a new website for its “Smart Drug” program to test and evaluate new and potentially more effective drugs.
It will be available through December 2020, according the DEA.